Patents by Inventor David I. Sterling

David I. Sterling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040204456
    Abstract: In one aspect, the present invention is directed to methods for treating fatigue, neurobehavioral slowing and other cognitive disorders and defects due to cancers and treatments associated with cancers, and similar conditions. In a further aspect, the present invention is directed to methods for treating disorders related to menopause, including executive function defects. The methods involve the administration of a composition comprising D-threo methylphenidate that is substantially free of L-threo methylphenidate and of erythro forms of methylphenidate.
    Type: Application
    Filed: April 8, 2004
    Publication date: October 14, 2004
    Applicant: Celgene Corporation
    Inventors: Jerome B. Zeldis, Andrew L. Zeitlin, Herbert J. Faleck, Vikram Khetani, Magsoud M. Dariani, David I. Sterling
  • Publication number: 20020198234
    Abstract: In one aspect, the present invention is directed to methods for treating fatigue, neurobehavioral slowing and other cognitive disorders and defects due to cancers and treatments associated with cancers, and similar conditions. In a further aspect, the present invention is directed to methods for treating disorders related to menopause, including executive function defects. The methods involve the administration of a composition comprising D-threo methylphenidate that is substantially free of L-threo methylphenidate and of erythro forms of methylphenidate.
    Type: Application
    Filed: July 16, 2002
    Publication date: December 26, 2002
    Applicant: WOODCOCK WASHBURN LLP
    Inventors: Jerome B. Zeldis, Herbert J. Faleck, Vikram Khetani, Andrew L. Zeitlin, Magsoud M. Dariani, David I. Sterling